Comparison of serum vascular endothelial growth levels between patients with and without ovarian malignancies

International Journal of Gynecological Cancer

Volumn 12, Issue 6, 2002, Pages 715-719

  Dehaven, K ^a   Taylor, D D ^a   Gercel Taylor, Cicek ^a,b  

^a University of Louisville School of Medicine   (United States)

^b NONE   (United States)

Author keywords

Ovarian cancer; Screening; VEGF

Indexed keywords

VASCULOTROPIN;

ARTICLE; BENIGN TUMOR; CANCER SCREENING; COMPARATIVE STUDY; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; OVARY CANCER; PRIORITY JOURNAL; RANK SUM TEST; STATISTICAL SIGNIFICANCE;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CYSTADENOCARCINOMA, PAPILLARY; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MIDDLE AGED; OVARIAN DISEASES; OVARIAN NEOPLASMS; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036855244     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.2002.t01-1-01143.x     Document Type: Article

References (20)

1. Oriel KA, Hartenbach EM, Remington PL. Trends in United States ovarian cancer mortality 1979-1995. Obstet Gynecol 1999;93:30-3.
2. Berek JS, Hacker NF. Practical Gynecologic Oncology, 2nd edn. Baltimore: Williams and Wilkins, 1994:334-5.
3. Folkman J. Clinical applications of research on angiogenesis. New Engl J Med 1995;333:1757-63.
4. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-5.
5. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86:353-64.
6. Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989;339:58-61.
7. Folkman J, Merler E, Abernathy C, Williams G. Isolation of a tumor factor responsible for angiogenesis. J Exp Med 1971;133:275-88.
8. Connolly D, Heuvelman DM, Nelson R et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989;84:1470-8.
9. Olson T, Mohanraj D, Carson L, Ramakrishnan S. Vascular permeability factor gene expression in normal and neoplastic human ovaries. Cancer Res 1994;54:276-80.
10. Abu-Jawdeh A, Faix JD, Niloff J et al. Strong expression of vascular permeability factor and its receptors in ovarian borderline and malignant neoplasms. Lab Invest 1996;74:1105-15.
11. Santin AD, Hermonat PL, Ravaggi A, Cannon MJ, Pecorelli A, Parhan GP. Secretion of vascular endothelial growth factor in ovarian cancer. Eur J Gynaecol Oncol 1999;20:177-81.
12. Yamamoto S, Konishi I, Mandai M et al. Expression of vascular endothelial growth factor in epithelial ovarian neoplasms: Correlation with clinicopathology and patient survival, and analysis of serum VEGF. Br J Cancer 1997;76:1221-7.
13. Nakanishi Y, Kodama J, Yoshinouchi M et al. The expression of vascular endothelial growth factor and transforming growth factor-β associates with angiogenesis in epithelial ovarian cancer. Int J Gynecol Pathol 1997;16:256-62.
14. Obermair A, Wasicky R, Kaider A et al. Prognostic significance of tumor angiogenesis in epithelial ovarian cancer. Cancer Lett 1999;138:175-82.
15. Paley P, Staskus KA, Gebhard K et al. Vascular endothelial growth factor expression in early stage ovarian carcinoma. Cancer 1997;80:98-106.
16. Tempfer C, Obermair A, Hefler L, Haeusler G, Gitsch G, Kainz C. Vascular endothelial growth factor serum concentrations in ovarian cancer. Obstet Gynecol 1998;92:360-3.
17. Guidozzi F. Screening for ovarian cancer. Obstet Gynecol Surv 1996;51:696-701.
18. Abulafia O, Sherer DM. Angiogenesis of the ovary. Am J Obstet Gynecol 2000;182:240-6.
19. George ML, Dzik-Jurasz AS, Padhani AR et al. Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer. Br J Surg 2001;88:1628-36.
20. Dittadi R, Meo S, Fabris F et al. Validation of blood collection procedures for the determination of circulating vascular endothelial growth factor (VEGF) in different blood compartments. Int J Biol Markers 2001;16:87-96.